Research and Development of Stem Cell & Regenerative Drugs
Stem cells are a number of undifferentiated cells that are characterized by the ability to multiply (regenerate), usually from a single cell (clonal), and divide into different types of cells and tissues (powerful). There are several sources of stem cells with different strengths. Pluripotent cells are embryonic stem cells found in the weight of the inner cell of the embryo and pluripotent cells are formed according to the reorganization of somatic cells. Pluripotent cells can divide into tissue in all 3 viral layers (endoderm, mesoderm, and ectoderm). The strongest stem cells can be divided into tissues found in the same cell layer as mesenchymal stem cells that form adipose tissue, bone, and cartilage. Stem-dwelling stem cells are oligopotent as they can form different death cells in a particular tissue. Stem cells can be used in cell therapy to replace damaged cells or to regenerate organs. In addition, stem cells increase our understanding of growth and pathogenesis of the disease. Disease-specific cell lines can also be distributed and used in drug development. Despite major advances in stem cell biology, issues such as behavioral conflicts with embryonic stem cells, tumor formation, and rejection limit their use. However, many of these limitations are being exceeded and this can lead to significant improvements in disease control. This is reviewed by the introduction of the stem cell world and discusses its meaning, origin, classification, and use of these cells in regenerative medicine.
Related Conference of Research and Development of Stem Cell & Regenerative Drugs
18th International Conference on Human Genomics and Genomic Medicine
21th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
16th International Conference on Human Genetics and Genetic Diseases
19th International Conference on Genomics & Pharmacogenomics
Research and Development of Stem Cell & Regenerative Drugs Conference Speakers
Recommended Sessions
- Stem Cell Therapy
- Stem Cells
- Bio Banking Stem cell
- Bone Marrow Transplantation
- Cell and Genetic Therapy
- Clinical Methods
- Dental Stem Cells
- Neurodegenerative Disease
- Regeneration and Therapeutics
- Research and Development of Stem Cell & Regenerative Drugs
- Stem Cell Animal Applications
- Stem Cell Apoptosis and Signal Transmission
- Stem Cell Embryology
- Stem Cell in Drug Discovery
- Stem Cell Transplantation
- Theories of Aging in Stem Biology
- Tissue Engineering
- Translational Research in Stem Cell Assessments
Related Journals
Are you interested in
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (France)
- Bioinformatics - HUMAN GENOME 2025 (France)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (France)
- Cancer Genomics - HUMAN GENOME 2025 (France)
- Cancer Stem Cells and Oncology - Stemgen 2026 (France)
- Cardiovascular Regeneration - Stemgen 2026 (France)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (France)
- Cognitive Computing - HUMAN GENOME 2025 (France)
- Computational Biology - HUMAN GENOME 2025 (France)
- Drug Detection & Development in Bioinformatics - HUMAN GENOME 2025 (France)
- Emergency Medicine - HUMAN GENOME 2025 (France)
- Epigenetics Biomarkers - HUMAN GENOME 2025 (France)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (France)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (France)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (France)
- Genetically Modified Organisms - HUMAN GENOME 2025 (France)
- Genome Mapping - HUMAN GENOME 2025 (France)
- Genomic Approach to Drug Discovery - HUMAN GENOME 2025 (France)
- Genomic Information in Medicine - HUMAN GENOME 2025 (France)
- Genomic Vaccination - HUMAN GENOME 2025 (France)
- Genomics - HUMAN GENOME 2025 (France)
- Human Gene Therapy - HUMAN GENOME 2025 (France)
- Human Genetics - HUMAN GENOME 2025 (France)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (France)
- Infectious Diseases - HUMAN GENOME 2025 (France)
- Medicine Genomics - HUMAN GENOME 2025 (France)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (France)
- Personalized Medicine - HUMAN GENOME 2025 (France)
- Pharma Genomics & Pharma Informatics - HUMAN GENOME 2025 (France)
- Preimplantation Genetic Diagnosis - HUMAN GENOME 2025 (France)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (France)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (France)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (France)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (France)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (France)
